Key Highlights
- MeMed's innovative diagnostic technology, the MeMed BV test, accurately distinguishes between bacterial and viral infections, reducing the need for unnecessary antibiotics and improving patient care.
- The company's proprietary technology has garnered significant attention and recognition in the medical community, positioning MeMed as a leader in the field of diagnostic testing.
- MeMed's commitment to innovation and excellence is evident in its research and development efforts, which focus on advancing diagnostic capabilities and improving patient outcomes.
- The company's team of experts in immunology and technology has established MeMed as a pioneer in the field of diagnostic testing, with a focus on transforming the way we approach infectious diseases and inflammatory disorders.
- MeMed's collaboration with leading medical institutions and investment in cutting-edge technologies demonstrate its dedication to improving patient care and advancing the field of diagnostic testing.
About MeMed
MeMed is a leading med tech and bio-convergence company based in Haifa, Israel, that has developed innovative diagnostic host immune response testing methods. These methods address complex clinical dilemmas and improve patient outcomes by translating the complex signals of the immune system into simple diagnostic insights. This transformative approach enables the right treatment of infectious diseases and inflammatory disorders at the right time. MeMed's mission is to revolutionize the way we diagnose and treat these conditions, providing healthcare professionals with critical information to make informed decisions.
Founded by a team of experts in immunology and technology, MeMed has established itself as a pioneer in the field of diagnostic testing. The company's proprietary technology, known as the MeMed BV test, has been shown to accurately distinguish between bacterial and viral infections, reducing the need for unnecessary antibiotics and improving patient care. MeMed's innovative approach has garnered significant attention and recognition in the medical community, positioning the company as a leader in the field of diagnostic testing.
MeMed's commitment to innovation and excellence is evident in its research and development efforts. The company continues to invest in cutting-edge technologies and collaborate with leading medical institutions to advance its diagnostic capabilities. With a team of over 100 employees, MeMed is dedicated to improving patient outcomes and transforming the way we approach infectious diseases and inflammatory disorders.
Leadership Team
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
Company Facts
| Ownership Private Company |
| Funding $163M |
Technology Stack
- Machine learning
- Immunoassay platform
- Host response technologies
Why Contact MeMed?
B2B professionals should contact MeMed for partnerships in the field of diagnostic testing, particularly for innovative solutions that improve patient outcomes and reduce unnecessary antibiotic use. MeMed's technology offers a unique value proposition for healthcare providers seeking to enhance their diagnostic capabilities and improve patient care.
Who Should Contact MeMed for Business?
Sales teams selling diagnostic testing solutions, healthcare providers seeking innovative diagnostic tools, and partners interested in collaborating with a leader in the field of diagnostic testing should reach out to MeMed.
Categories
- diagnostic testing
- immune response
- infectious diseases
- inflammatory disorders
- MeMed BV test
- med tech
- bio-convergence
- patient outcomes
- antibiotic reduction
- healthcare innovation
Frequently Asked Questions
- Who is the CEO of MeMed?
- Dr. Eran Eden is the CEO of MeMed.
- What is Eran Eden's email at MeMed?
- Eran Eden's email address is eran.eden@me-med.com.
- What does MeMed do?
- MeMed is a med tech and bio-convergence company that develops diagnostic host immune response testing methods, such as MeMed BV®, to distinguish between bacterial and viral infections and improve patient outcomes in infectious diseases and inflammatory disorders.
- How many employees does MeMed have?
- MeMed has approximately 109 total employees.
- Where is MeMed headquartered?
- The company is headquartered in Tirat Carmel, Israel.
- What industry is MeMed in?
- MeMed operates in Diagnostic Testing, Medical Technology, Infectious Disease Management.
- When was MeMed founded?
- MeMed was founded in 2009.
- What is the email format at MeMed?
- MeMed uses the email format first.last@me-med.com.
- How do I contact the founder of MeMed?
- The founder of MeMed can be contacted at kfir.oved@me-med.com.
- Is MeMed still active?
- Yes, MeMed was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to MeMed?
- Research MeMed's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to MeMed?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with MeMed